Merck Sharp & Dohme Corp.'s Net Worth

$1.18 Billion

Who is Merck Sharp & Dohme Corp.?

Merck Sharp & Dohme Corp. has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include OPGEN INC, BeiGene, Ltd., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..

SEC CIK

Merck Sharp & Dohme Corp.'s CIK is 0000942443

Past Insider Trading and Trends

2016 was Merck Sharp & Dohme Corp.'s most active year for acquiring shares with 8 total transactions. Merck Sharp & Dohme Corp.'s most active month to acquire stocks was the month of January. 2016 was Merck Sharp & Dohme Corp.'s most active year for disposing of shares, totalling 2 transactions. Merck Sharp & Dohme Corp.'s most active month to dispose stocks was the month of January. 2019 saw Merck Sharp & Dohme Corp. paying a total of $65,946,928.00 for 12,955,016 shares, this is the most they've acquired in one year. In 2018 Merck Sharp & Dohme Corp. cashed out on 74,794,315 shares for a total of $0.00, their largest year based on trade value.